Tuesday, February 6, 2018

Nature Biotechnology Contents: Volume 36 pp 117 - 204

If you are unable to see the message below, click here to view.
Nature Biotechnology


Advertisement
Bioprocessing Technologies in Stem Cell Research:
Perspectives on Process Design, Scale-Up, and Product Safety


The 2nd Stem Cell Community Day brings together experts from industry and academia to discuss recent achievements, challenges, and chances in stem cell bioprocessing for research and commercial manufacturing. Register now and submit your abstract! 
www.stemcellday.de
TABLE OF CONTENTS

February 2018 Volume 36, Issue 2

Editorials
News
Opinion and Comment
Features
News and Views
Research
Careers and Recruitment

Advertisement
 
Discover a new path to your success via Human Data Science. IMS Health and Quintiles are now IQVIA™ - created to advance your pursuits of human science by unleashing the power of data science and human ingenuity. We are here to help you find solutions to drive healthcare forward.

Join the journey today.


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 

Advertisement
A*STAR Research - Highlighting the latest breakthroughs at the Agency for Science, Technology and Research (A*STAR), Singapore's premier research organization

Recent Highlights 

Nanomedicine: Taking a stab at microbes | Oncology: All in a molecule of water for effective cancer therapy | Microcapsules: Getting functional proteins from A to B  

Download the A*STAR Research app now!
 
Advertisement

BIOPHARMA DEALMAKERS
BIOPHARMA DEALMAKERSCompany Profiles and Partnering Opportunities


 

Advertisement
Nature Outlook: Cancer immunotherapy 

Drugs that mobilize our immune systems against cancer are dramatically improving care for many people, and research is rapidly moving ahead in the lab and the clinic. 

Access this Outlook free >> 

Produced with support from 
F. Hoffmann-La Roche Ltd  
Medimmune 
Produced with support of a grant from Merck & Co., Inc.
 

Editorials

A less than ideal Deal   p117
doi:10.1038/nbt.4084
The UK government's strategic plan for the life sciences is short on ambition and capital.

No research in Correspondence   p117
doi:10.1038/nbt.4085
Nature Biotechnology will no longer publish research in its Correspondence section.

News

FDA warns public of dangers of DIY gene therapy   pp119 - 120
Eric Smalley
doi:10.1038/nbt0218-119

Gut bacteria link to immunotherapy sparks interest   pp121 - 123
Brian Owens
doi:10.1038/nbt0218-121

Spark's gene therapy price tag: $850,000   p122
doi:10.1038/nbt0218-122

Roche pays $1.7 billion to target tumors' genetic signatures   p123
doi:10.1038/nbt0218-123

Approval of first tumor gene panel sends shockwaves through labs   pp124 - 125
Mark Ratner
doi:10.1038/nbt0218-124

California voters and CIRM—will lightning strike twice?   pp126 - 127
Laura DeFrancesco
doi:10.1038/nbt0218-126

Around the world in a month   p127
doi:10.1038/nbt0218-127

US tax reform may jeopardize orphans   p128
Chris Morrison
doi:10.1038/nbt0218-128

Data Page

2017—venture funding goes into overdrive   p129
Laura DeFrancesco
doi:10.1038/nbt.4081

Drug pipeline: 4Q17   p130
Laura DeFrancesco
doi:10.1038/nbt.4073

News Feature

Fresh from the biotech pipeline—2017   pp131 - 136
Chris Morrison
doi:10.1038/nbt.4068
A positive regulatory environment, combined with a raft of drug approvals that included the first US gene therapy, buoyed the sector in 2017. The FDA's flexibility and focus on marketplace competition is likely to galvanize innovators in the coming year. Chris Morrison reports.

Opinion and Comment

Correspondence

Rationalizing governance of genetically modified products in developing countries   pp137 - 139
Ademola A Adenle, E Jane Morris, Denis J Murphy, Peter W B Phillips, Eduardo Trigo et al.
doi:10.1038/nbt.4069

An alternative proposal to the destruction of abandoned human embryos   pp139 - 141
Norbert Gleicher and Arthur L Caplan
doi:10.1038/nbt.4070

Faster, Simpler Biological LC-MS/MS Analysis 

Shimadzu's Clinical Laboratory Automation Module, a fully integrated sample pretreatment module for LC-MS/MS, automatically performs all of the processes necessary for analyzing blood and other biological samples, providing more precise results by reducing human error and improving laboratory safety and efficiency. Learn more.

Features

Patents

Tertiary patenting on drug-device combination products in the United States   pp142 - 145
Reed F Beall and Aaron S Kesselheim
doi:10.1038/nbt.4078
Drug-device combination products are becoming increasingly prevalent, with many lasting years beyond the expiration date of primary and secondary patents on the drug itself.

Recent patents in neoantigens and neoepitopes   p146
doi:10.1038/nbt.4083

Naturejobs Career Guide China 2018 

China's scientific landscape is shifting fast. Where can you fit in? Read the latest issue of our career guide to see what opportunities await you. 

Read more online >> 
 

News and Views

PrePAIRing Cas9s for screening success   pp147 - 148
Zhuo Zhou and Wensheng Wei
doi:10.1038/nbt.4075
Orthogonal CRISPR-Cas9 nucleases enable more efficient high-throughput screens for deciphering genetic interactions.

See also: Research by Boettcher et al. | Research by Najm et al.

Making brain proteomics true to type   pp149 - 150
Rashaun S Wilson and Angus C Nairn
doi:10.1038/nbt.4077
Two independent but related strategies use unnatural amino acid incorporation to enable in vivo cell-type-specific proteomics in the mouse brain.

See also: Research by Krogager et al.

Research Highlights   p150
doi:10.1038/nbt.4076

Putting a number on neoepitope quality   p151
Irene Jarchum
doi:10.1038/nbt.4074

Biotechnology
JOBS of the week
Postdoctoral Fellow
University of Pennsylvania - Perelman School of Medicine
Postdoctoral Fellow
University Health Network (Toronto)
Bioinformatician / Computational Biologist (PhD)
University of Helsinki
PhD Students and Postdoctoral Scientists
University Medical Center Freiburg
Postdoc
University of Virginia
More Science jobs from
Biotechnology
EVENT
International Conference on Biotechnology & Environmental Science
March 18, 2018
New Delhi, India
More science events from

Research

Brief Communications

Functional interrogation and mining of natively paired human VH:VL antibody repertoires   pp152 - 155
Bo Wang, Brandon J DeKosky, Morgan R Timm, Jiwon Lee, Erica Normandin et al.
doi:10.1038/nbt.4052
Libraries of natively paired human VH:VL chains enable screening of the human B-cell repertoire in yeast.

Labeling and identifying cell-specific proteomes in the mouse brain   pp156 - 159
Toke P Krogager, Russell J Ernst, Thomas S Elliott, Laura Calo, Vaclav Beranek et al.
doi:10.1038/nbt.4056
Labeling of cell-type-specific proteomes in the brains of live mice is enabled by an orthogonal-amino-acid approach.

See also: News and Views by Wilson & Nairn

Articles

Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells   pp160 - 169
Alexander S Cheung, David K Y Zhang, Sandeep T Koshy and David J Mooney
doi:10.1038/nbt.4047
T cells are readily expanded in culture using a system that presents membrane-bound and soluble cues in a natural context.

Dual gene activation and knockout screen reveals directional dependencies in genetic networks   pp170 - 178
Michael Boettcher, Ruilin Tian, James A Blau, Evan Markegard, Ryan T Wagner et al.
doi:10.1038/nbt.4062
Combining gene activation and knockout of different genes in the same cell using two different Cas9 enzymes enables the reconstruction of directional dependency.

See also: News and Views by Zhou & Wei

Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens   pp179 - 189
Fadi J Najm, Christine Strand, Katherine F Donovan, Mudra Hegde, Kendall R Sanson et al.
doi:10.1038/nbt.4048
Combinatorial CRISPR screens are improved by using Cas9 enzymes from two different organisms.

See also: News and Views by Zhou & Wei

Letter

Retrieval of a million high-quality, full-length microbial 16S and 18S rRNA gene sequences without primer bias   pp190 - 195
Soren M Karst, Morten S Dueholm, Simon J McIlroy, Rasmus H Kirkegaard, Per H Nielsen et al.
doi:10.1038/nbt.4045
More of the diversity present in any microbiome is revealed by a method to sequence 16S rRNA that avoids primer bias.

Corrigenda

Corrigendum: Minimum information about a single amplified genome (MISAG) and a metagenome-assembled genome (MIMAG) of bacteria and archaea   p196
Robert M Bowers, Nikos C Kyrpides, Ramunas Stepanauskas, Miranda Harmon-Smith, Devin Doud et al.
doi:10.1038/nbt0218-196a

Corrigendum: Assisted reproductive technologies to prevent human mitochondrial disease transmission   p196
Andy Greenfield, Peter Braude, Frances Flinter, Robin Lovell-Badge, Caroline Ogilvie et al.
doi:10.1038/nbt0218-196b

Corrigendum: Reproducing with DNA   p196
Malorye Allison Branca
doi:10.1038/nbt0218-196c

Erratum

Erratum: Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells   p196
Trung Van Chu, Timm Weber, Benedikt Wefers, Wolfgang Wurst, Sandrine Sander et al.
doi:10.1038/nbt0218-196d

Careers and Recruitment

Visualizing detailed postdoctoral employment trends using a new career outcome taxonomy   pp197 - 202
Hong Xu, Richard S T Gilliam, Shyamal D Peddada, Gregory M Buchold and Tammy R L Collins
doi:10.1038/nbt.4059
A standard taxonomy and visualization methods can provide postdoctoral scholars with tools to critically evaluate their career prospects.

People

People   p204
doi:10.1038/nbt.4082

Advertisement
Nature Mentoring Collection 

Offering advice and support to scientist mentors and their mentees 

Access the Collection >> 
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: